| Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin. | |
| | |
MedLine Citation:
|
PMID: 22212570 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The addition of telaprevir or boceprevir to pegylated interferon (PEG-INF) and ribavirin (RBV) has improved sustained viral response (SVR) rates in genotype-1-infected individuals. The recent publication of Phase III trials has made it possible to examine pretreatment and on-treatment predictors of response in genotype 1 naïve patients. Both telaprevir- and boceprevir-based therapy improve SVR rates in most treatment groups including individuals who are difficult-to-treat such as those with a high viral load, Black patients and those with advanced fibrosis. Although data sets were not complete, patients with IL28B CT and TT genotype appear to significantly improve when these agents are combined with PEG-INF and RBV. The presence of the IL-28B CC genotype appears to be predictive for a short duration of therapy. On-treatment viral response is also predictive of the SVR: approximately half of the patients are successfully treated with short duration and response-guided therapy. |
| | |
Authors:
|
Paul Y Kwo |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Liver international : official journal of the International Association for the Study of the Liver Volume: 32 Suppl 1 ISSN: 1478-3231 ISO Abbreviation: Liver Int. Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101160857 Medline TA: Liver Int Country: England |
Other Details:
|
Languages: eng Pagination: 39-43 Citation Subset: IM |
Copyright Information:
|
© 2012 John Wiley & Sons A/S. |
Affiliation:
|
Liver Transplantation Gastroenterology/Hepatology Division, Indiana University School of Medicine, Indianapolis, IN, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical pr...
Next Document: Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-r...